Author: Tamara Schneider

Senior Medical Sciences Writer Office of Biomedical Strategy, Marketing and Communications

Nasal COVID-19 vaccine based on WashU technology to enter U.S. clinical trials (Links to an external site)

The investigational nasal vaccine was co-developed by WashU Medicine scientists Michael S. Diamond, MD, PhD, the Herbert S. Gasser Professor of Medicine and the co-director of the Center for Vaccines & Immunity to Microbial Pathogens, and David T. Curiel, MD, PhD, the Distinguished Professor of Radiation Oncology, along with members of their laboratories.

Jacco Boon, PhD and colleagues have developed a tool to study how viruses spread

Each colored stripe in the image above represents a unique virus particle, with the width of each stripe reflecting the number of copies, in a hamster infected with SARS-CoV-2, the virus that causes COVID-19. Jacco Boon, PhD, a professor of medicine in the Division of Infectious Diseases, and colleagues have developed a tool to study […]